@article{f034dd39f0df409887cd13827651f6f6,
title = "Practical considerations and consensus opinion for children{\textquoteright}s hospital–based inpatient hemostasis and thrombosis (HAT) consultative services: Communication from the ISTH SSC Subcommittee on Pediatric/Neonatal Thrombosis and Hemostasis",
abstract = "Caring for children and adolescents with disorders of hemostasis and thrombosis (HAT) has become more specialized and requires a unique skill set that many providers are not able to obtain in standard pediatric hematology/oncology/bone marrow transplant fellowship training programs. The influx of numerous therapeutic advances and increasing medical complexity has expanded the need for experienced HAT providers and subspecialty collaboration in the inpatient setting due to the nuances in the management of patients with HAT complications and concerns. While there are data highlighting the benefits of an inpatient hemostasis, thrombosis, and anticoagulation management service in adult hospitals, there are limited pediatric data supporting such programs. In this article, we summarize the current practices of various pediatric institutions in the inpatient management of HAT patients and provide a consensus opinion for the development of a pediatric inpatient HAT service at tertiary care referral centers.",
keywords = "consultation, hemostasis, inpatient, pediatric, thromboembolism",
author = "Woods, {Gary M.} and Leslie Raffini and Brand{\~a}o, {Leonardo R.} and Julie Jaffray and Branchford, {Brian R.} and Ng, {Christopher J.} and Sartain, {Sarah E.} and Jennifer Pak and Christoph Male and Ayesha Zia and Mattia Rizzi and Nongnuch Sirachainan and Faustino, {Edward Vincent S.} and Carpenter, {Shannon L.} and Goldenberg, {Neil A.}",
note = "Funding Information: G. M. Woods has received consultancy fees for advisory roles from the following companies: Takeda. L. Raffini, L. R. Brand{\~a}o, and J. Jaffray declare no relevant conflicts of interest. B. R. Branchford has received consultancy fees for advisory roles from the following companies: BioProducts Laboratories. C. J. Ng has received consultancy fees for advisory roles from the following companies: Takeda and CSL Behring. C. J. Ng has received research support from CSL Behring. S. E. Sartain has received consultancy fees for advisory roles as well as research funding from the following companies: Alexion Pharmaceuticals. J. Pak declares no relevant conflicts of interest. C. Male has received consultancy fees for advisory roles from the following companies: Anthos, Bayer, Boehringer Ingelheim, Bristol‐Myers‐Squibb, CSL Behring, Janssen, Novo Nordisk, Pfizer, Roche, and Takeda. A.Z receives salary support from NIH NHLBI and the American Heart Association. She has received consultancy fees for advisory roles from Sanofi Genzyme and Takeda. M. Rizzi declares no relevant conflicts of interest. N. Sirachainan declares no relevant conflicts of interests. E. V. S Faustino has received grant support from NIH and Grifols Shared Services of North America and honorarium for medical advisory board member for Boehringer Ingelheim. S. L. Carpenter has received honoraria from Genentech, Kedrion, and Novo Nordisk. She is also on the Board of the Hemostasis and Thrombosis Research and is the Editor of PREP Hematology/Oncology of the American Academy of Pediatrics. N. A. Goldenberg receives research support and salary support from the National Institutes of Health, National Heart Lung and Blood Institute for clinical and translational investigation in venous thromboembolism in patients <21 years old. He receives or had recently received consultancy fees from Anthos Therapeutics, Bayer, Boehringer‐Ingelheim, Chiesi, Daiichi Sankyo Inc., Novartis, and the Academic Research Organization CPC Clinical Research for roles in clinical trial design and oversight committees (e.g., advisory, steering, data and safety monitoring) in pharmaceutical industry‐sponsored pediatric clinical trials. Publisher Copyright: {\textcopyright} 2022 International Society on Thrombosis and Haemostasis.",
year = "2022",
doi = "10.1111/jth.15798",
language = "English (US)",
journal = "Journal of Thrombosis and Haemostasis",
issn = "1538-7933",
publisher = "Wiley-Blackwell",
}